<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Key histopathologic findings in selected hyperpigmentation disorders</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Key histopathologic findings in selected hyperpigmentation disorders</h1>
<div class="graphic"><div class="figure"><div class="ttl">Key histopathologic findings in selected hyperpigmentation disorders</div><div class="cntnt"><table cellspacing="0"><colgroup width="40%"></colgroup><colgroup width="60%"></colgroup> <tbody> <tr> <td class="subtitle1">Selected disorders</td> <td class="subtitle1">Key histopathologic findings</td> </tr> <tr class="divider_bottom"> <td>Acanthosis nigricans</td> <td> <ul> <li>Hyperkeratosis and papillomatosis of the epidermis </li> <li>Basal layer hyperpigmentation </li> <li>Minimal acanthosis (misnomer) </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Actinic lichen planus</td> <td> <ul> <li>Variable with typical findings of lichen planus including hyperkeratosis without parakeratosis, hypergranulosis, irregular acanthosis with "saw-toothed" rete ridges, liquefaction degeneration of the basal layer, and band-like lymphocytic infiltrate at the dermal-epidermal junction </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Addison's disease<sup>[1]</sup></td> <td> <ul> <li>Increased basal layer melanin, sometimes melanin incontinence </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Becker's melanosis<sup>[2]</sup></td> <td> <ul> <li>Variable papillomatosis, acanthosis, and hyperkeratosis </li> <li>Regular elongation of the rete ridges with or without pilosebaceous unit hyperplasia </li> <li>May have increased hair follicles or smooth muscle </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Caf√©-au-lait macules<sup>[1]</sup></td> <td> <ul> <li>Increased melanin in the basal layer </li> <li>Normal number of hyperactive melanocytes </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Dermal melanocytosis<sup>[1]</sup></td> <td> <ul> <li>Spindle-shaped dendritic melanocytes in the deep dermis with abundant fine granules of melanin </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Diabetes mellitus - diabetic dermopathy<sup>[1]</sup></td> <td> <ul> <li>Dermal hemosiderin, increased papillary dermal blood vessels, sparse perivascular lymphocytes </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Diabetes mellitus - necrobiosis lipoidica</td> <td> <ul> <li>Diffuse palisaded and interstitial granulomatous dermatitis with tiers of granulomatous inflammation (includes multinucleated histiocytes) aligned parallel to the surface </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Dowling-Degos</td> <td> <ul> <li>Delicate, elongated, hyperpigmented rete ridges </li> <li>Sometimes resembles a reticulated seborrheic keratosis </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Drug-induced hyperpigmentation<sup>[1]</sup></td> <td> <ul> <li>Variable depending on drug or chemical: <ul> <li>Minocycline: brown dermal pigment that is positive with iron and melanin stains </li> <li>Gold: chrysiasis pigment appears as black particles </li> <li>Bleomycin: basal layer with increased melanin </li> <li>Clofazimine: brown lipofuscin that stains with PAS </li> <li>Amiodarone: brown pigment that stains with PAS </li> </ul> </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Ephelides<sup>[1]</sup></td> <td> <ul> <li>Increased melanin in basal layer </li> <li>Normal or decreased number of hyperactive melanocytes </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Erythema dyschromicum perstans<sup>[1]</sup></td> <td> <ul> <li>Liquefaction degeneration of the basal layer </li> <li>Melanin incontinence </li> <li>Interface changes with perivascular or interface lymphocytes </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Erythromelanosis follicularis faciei et colli<sup>[3]</sup></td> <td> <ul> <li>Hyperkeratosis </li> <li>Dilatation of superficial dermal blood vessels </li> <li>Follicular plugging </li> <li>Variable melanin in basal layer </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Exogenous ochronosis<sup>[1]</sup></td> <td> <ul> <li>Yellow-brown "banana-shaped" deposits on homogenized collagen bundles </li> <li>Small yellow-brown granules in endothelial cells and sweat glands </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Hemochromatosis<sup>[1]</sup></td> <td> <ul> <li>Increased melanin in the basal layer </li> <li>Hemosiderin deposits scattered in the dermis, usually around blood vessels and sweat glands, best seen with Perl's stain </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Lentigines<sup>[1]</sup></td> <td> <ul> <li>Hyperpigmented, often elongated rete ridges, usually with increased melanocytes </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Lichen planus pigmentosus</td> <td> <ul> <li>Similar to erythema dyschromicum perstans with marked pigment incontinence and epidermal atrophy </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Melasma<sup>[4]</sup></td> <td> <ul> <li>Increased melanin deposition in all layers of the epidermis </li> <li>Solar elastosis </li> <li>More abundant mast cells </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Nevus of Ota, Nevus of Ito, Hori's nevi<sup>[1]</sup></td> <td> <ul> <li>Normal epidermis </li> <li>Spindle-shaped dendritic melanocytes in the dermis with abundant fine granules of melanin </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Nevus spilus</td> <td> <ul> <li>Lentiginous melanocytic hyperplasia </li> <li>Papular foci represent junctional, compound, blue, Spitz, and/or atypical nevi </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Periorbital hyperpigmentation<sup>[5,6]</sup></td> <td> <ul> <li>Dermal melanocytosis and melanin in upper dermal macrophages (melanophages) </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Post-chikungunya pigmentation<sup>[7,8]</sup></td> <td> <ul> <li>Intact basal layer with diffuse hypermelanosis of the entire epidermis </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Postinflammatory hyperpigmentation</td> <td> <ul> <li>Increased or normal amount of melanin at basal layer, with or without melanin incontinence based on etiology </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Primary cutaneous amyloidosis<sup>[1]</sup></td> <td> <ul> <li>Macular amyloidosis with subtle amyloid globules in the papillary dermis in areas of melanin incontinence </li> <li>Lichen amyloidosis with small deposits of amyloid in the dermal papillae </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Riehl's melanosis<sup>[1]</sup></td> <td> <ul> <li>Lymphocytic perivascular or interface dermatitis with melanin incontinence </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Smoker's melanosis</td> <td> <ul> <li>Mucosal surface with basal layer melanosis, with or without melanin incontinence </li> </ul> </td> </tr> <tr> <td>Terra firma-forme dermatosis<sup>[9]</sup></td> <td> <ul> <li>Prominent lamellar hyperkeratosis with focal areas having compact orthokeratosis in whorls </li> </ul> </td> </tr> </tbody></table></div><div class="graphic_footnotes">PAS: periodic acid-Schiff.</div><div class="graphic_reference">References:<br/><ol>
<li>Rapini RP. Practical Dermatopathology, 2nd ed, Saunders, Philadelphia 2012.</li>
<li>Cohen PR. Becker's nevus. Am Fam Physician 1988; 37:221.</li>
<li>Kim MG, Hong SJ, Son SJ, et al. Quantitative histopathologic findings of erythromelanosis follicularis faciei et colli. J Cutan Pathol 2001; 28:160.</li>
<li>Kang WH, Yoon KH, Lee ES, et al. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol 2002; 146:228.</li>
<li>Malakar S, Lahiri K, Banerjee U, et al. Periorbital melanosis is an extension of pigmentary demarcation line-F on face. Indian J Dermatol Venereol Leprol 2007; 73:323.</li>
<li>Watanabe S, Nakai K, Ohnishi T. Condition known as "dark rings under the eyes" in the Japanese population is a kind of dermal melanocytosis which can be successfully treated by Q-switched ruby laser. Dermatol Surg 2006; 32:785.</li>
<li>Khanna N, Rasool S. Facial melanoses: Indian perspective. Indian J Dermatol Venereol Leprol 2011; 77:552.</li>
<li>Inamadar AC, Palit A, Sampagavi VV, et al. Cutaneous manifestations of chikungunya fever: observations made during a recent outbreak in south India. Int J Dermatol 2008; 47:154.</li>
<li>Browning J, Rosen T. Terra firma-forme dermatosis revisited. Dermatol Online J 2005; 11:15.</li>
</ol></div><div id="graphicVersion">Graphic 95321 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
